LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. BTX,
announced today the release of LifeMap Discovery^TM version 1.1
(discovery.lifemapsc.com). LifeMap Discovery^TM is a key component in
LifeMap's integrated database suite, a discovery platform for biomedical and
stem cell research, which also includes GeneCards^®, the leading human gene
database, and MalaCards, the human disease database. LifeMap Discovery^TM
version 1.1 includes significant enhancements of content related to disease
targets for stem cell therapy, cells involved in various diseases (such as
Parkinson's disease and age related macular degeneration), and a large number
of newly added genes relevant to developmental and stem cell biology.
According to Google Analytics, the integrated database suite had more than
13,000,000 page views and more than 2,000,000 unique visitors in the past 12
months. LifeMap clients and partners include dozens of large, fee-paying
pharmaceutical and biotechnology companies, as well as leading government
patent offices, and its products are used free of charge by scientists at more
than a thousand academic institutions worldwide. The integrated database suite
also provides a technological foundation for the potential development of
additional LifeMap databases and services that will leverage significant and
growing web traffic. Moreover, the platform drives life scientists to the
LifeMap BioReagents™ portal, which offers cutting-edge stem cell reagents.
LifeMap Discovery™ itself is rapidly becoming utilized by researchers and has
already reached an audience of 10,000 unique visitors since its launch in
November 2012 according to Google Analytics, demonstrating the power of
integration between the databases to drive rapid user-base growth across
various components of the integrated database suite.
LifeMap Discovery™ is a state-of-the-art roadmap of embryonic development and
stem cell biology. The platform integrates embryonic development and stem cell
biology with molecular, cellular, anatomical, and disease-related information,
and provides data-mining capabilities and bioinformatics applications. LifeMap
Discovery™ is a unique and powerful tool for research and discovery in
multiple disciplines, including stem cell biology, developmental biology and
disease mechanisms and etiology. The platform is not only valuable for
clinical applications involving stem differentiation and therapies, it will
continue to be a key to future product development.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in